Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives

Systemic treatment with hedgehog inhibitors (HHis) is available to treat basal cell carcinomas but their utility is limited by adverse effects. Topical delivery methods may reduce adverse effects, but successful topical treatment depends on sufficient skin uptake, biological response, and time in tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Kristian Kåber, Høyer-Hansen, Maria Helena, Litman, Thomas, Hædersdal, Merete, Olesen, Uffe Høgh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692957/
https://www.ncbi.nlm.nih.gov/pubmed/36430669
http://dx.doi.org/10.3390/ijms232214191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692957/
https://www.ncbi.nlm.nih.gov/pubmed/36430669
http://dx.doi.org/10.3390/ijms232214191

Ejemplares similares